From the party to the therapy – MDMA as an alternative for the existing methods of Post-traumatic Stress Disorder treatment [PDF]
, 2023 Introduction: Post-traumatic Stress Disorder (PTSD) is a mental illness caused by exposure to a traumatic event. The current treatment includes trauma-focused psychotherapy along with selective serotonin reuptake inhibitors (SSRI).
Bojarska, Wiktoria +7 more
core +2 more sources
USO DE 3,4-METILENODIOXMETANFETAMINA NO TRATAMENTO DE TRANSTORNO DE ESTRESSE PÓS-TRAUMÁTICO [PDF]
, 2022 Introduction: Post-traumatic stress disorder (PTSD) is characterized by persistent intense reactions to memories of a traumatic event. In recent years, there have been several neuroscientific and clinical studies examining the potential of 3,4 ...
Alencastro Costa Moreira, Camila +9 more
core +2 more sources
Development and validation of a color spot test method for the presumptive detection of 25-NBOMe compounds. [PDF]
, 2022 The great increase of new psychoactive substances over the past decade has substantially transformed the illicit drug industry to an ever-changing dynamic market.
Clancy, L, Fu, S, Philp, M, Shimmon, R
core +1 more source
Expanded access to psychedelic treatments: comparing American and Canadian policies. [PDF]
Gen PsychiatrGeneral Psychiatry, Volume 38, Issue 1, February 2025.
Richard J +2 more
europepmc +2 more sources
The Effectiveness of Oxytocin for Treating Substance Use Disorders:A Systematic Review of Randomized Placebo-controlled Trials [PDF]
, 2023 Oxytocin is gaining traction in the treatment of various substance use disorders (SUD). We performed a systematic review assessing the efficacy of oxytocin for treating different SUD.
Fink-Jensen, Anders +6 more
core +1 more source
Therapeutic role of psilocybin and 3,4-methylenedioxymethamphetamine in trauma: A literature review. [PDF]
, 2023 With the Food and Drug Administration designation in 2017 of 3,4-methylenedioxymethamphetamine (MDMA) as a breakthrough therapy in post-traumatic stress disorder and psilocybin in treatment-resistant depression, psychedelic drugs have continued to garner
Fonseka, Lakshan, Woo, Benjamin
core +1 more source
Exposure to 3,4-methylenedioxymethamphetamine (MDMA) induced biochemical but not behavioral effects in Daphnia magna [PDF]
, 2023 Among amphetamine like stimulants (ATS), the 3,4-methylenedioxymethamphetamine (MDMA) is often de- tected in sewage and surface waters, representing a potential threat for organisms because of its peculiar mecha- nism of action (i.e., stimulatory and ...
B. De Felice, M. Parolini
core +1 more source
Development and validation of a presumptive colour spot test method for the detection of piperazine analogues in seized illicit materials [PDF]
, 2013 The increasingly large quantities of potentially illicit samples received for confirmatory analysis highlights the importance and demand for preliminary testing procedures that are simple, rapid, selective, inexpensive and able to be used in the field ...
Fu, S +4 more
core +1 more source
Molecular basis of the selective binding of MDMA enantiomers to the Alpha4Beta2 nicotinic receptor subtype: synthesis, pharmacological evaluation and mechanistic studies [PDF]
, 2017 The α4β2 nicotinic acetylcholine receptor (nAChR) is a molecular target of 3,4-methylenedioxymethamphetamine (MDMA), a synthetic drug also known as ecstasy, and it modulates the MDMA-mediated reinforcing properties.
Borrell, José Ignacio +8 more
core +1 more source
Detection of Drugs of Abuse by Raman Spectroscopy [PDF]
, 2011 Raman spectroscopy can provide rapid, sensitive, non-destructive analysis of a variety of drug types (e.g. amphetamines, alkaloids, designer drugs and date rape drugs). This review concentrates on developments in the past 15 years.
Ali +45 more
core +1 more source